Publicacions en què col·labora amb Carmen Bellas Menéndez (10)

2011

  1. Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells

    Modern Pathology, Vol. 24, Núm. 5, pp. 698-707

2008

  1. Erratum: Frequency of BCL2 and BCL6 translocations in follicular lymphoma: Relation with histological and clinical features (Leukemia and Lymphoma (2008) vol. 49(1) (95-101))

    Leukemia and Lymphoma

  2. Frequency of BCL2 and BCL6 translocations in follicular lymphoma: Relation with histological and clinical features

    Leukemia and Lymphoma, Vol. 49, Núm. 1, pp. 95-101

2006

  1. Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma

    Blood, Vol. 108, Núm. 2, pp. 662-668

2003

  1. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: Analyses using tissue microarrays

    Blood, Vol. 101, Núm. 2, pp. 681-689

2000

  1. Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's disease treated with chemotherapy

    Leukemia and Lymphoma, Vol. 39, Núm. 5-6, pp. 563-572

1999

  1. Other cancers in patients with gastric MALT lymphoma

    Leukemia and Lymphoma, Vol. 33, Núm. 1-2, pp. 161-168

1997

  1. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr Virus-latent membrane protein 1 expression

    Blood, Vol. 90, Núm. 6, pp. 2429-2436

1996

  1. Evaluation of the international index in the prognosis of high grade gastric malt lymphoma

    Leukemia and Lymphoma, Vol. 24, Núm. 1-2, pp. 159-163

1995

  1. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients

    Annals of Oncology, Vol. 6, Núm. 4, pp. 355-362